Cargando…

Identification and Validation of Immune Markers in Coronary Heart Disease

BACKGROUND: Coronary heart disease (CHD) is an ischemic heart disease involving a variety of immune factors. This study was aimed at investigating unique immune and m6A patterns in patients with CHD by gene expression in peripheral blood mononuclear cells (PBMCs) and at identifying novel immune biom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Yuxiong, Zhang, Jian, Li, Jin, Zhao, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439891/ https://www.ncbi.nlm.nih.gov/pubmed/36060667 http://dx.doi.org/10.1155/2022/2877679

Ejemplares similares

Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases
por: Prentice, Ross L, et al.
Publicado: (2013)

Markers of Inflammation and Risk of Coronary Heart Disease
por: Sarwar, Nadeem, et al.
Publicado: (2009)

Hypomethylation of ABCG1 in peripheral blood as a potential marker for the detection of coronary heart disease
por: Jin, Jialie, et al.
Publicado: (2023)

CPE Regulates Proliferation and Apoptosis of Primary Myocardial Cells Mediated by Ischemia and Hypoxia Injury
por: Li, Jin, et al.
Publicado: (2022)

Platelet-to-hemoglobin ratio as a valuable predictor of long-term all-cause mortality in coronary artery disease patients with congestive heart failure
por: Bao, Kunming, et al.
Publicado: (2021)

Erythrocyte sedimentation rate as a marker for coronary heart disease
por: Yayan, Josef
Publicado: (2012)

Study on Qi Deficiency Syndrome Identification Modes of Coronary Heart Disease Based on Metabolomic Biomarkers
por: Shi, Qi, et al.
Publicado: (2014)

Identification and validation of potential hypoxia-related genes associated with coronary artery disease
por: Jin, Yuqing, et al.
Publicado: (2023)

Inflammation markers are associated with frailty in elderly patients with coronary heart disease
por: Hou, Ping, et al.
Publicado: (2018)

In silico identification of common and specific signatures in coronary heart diseases
por: Yang, Zhijia, et al.
Publicado: (2020)

Study on TCM Syndrome Identification Modes of Coronary Heart Disease Based on Data Mining
por: Shi, Qi, et al.
Publicado: (2012)

Improvement of the Accuracy in the Identification of Coronary Artery Disease Combining Heart Sound Features
por: Li, Haixia, et al.
Publicado: (2022)

Identification and Experimental Validation of Marker Genes between Diabetes and Alzheimer's Disease
por: Huang, Cheng, et al.
Publicado: (2022)

Identification and validation of immune and oxidative stress-related diagnostic markers for diabetic nephropathy by WGCNA and machine learning
por: Xu, Mingming, et al.
Publicado: (2023)

Establishment and Validation of a Non-invasive Diagnostic Nomogram to Identify Heart Failure in Patients With Coronary Heart Disease
por: Tan, Juntao, et al.
Publicado: (2022)

Identification of genetic loci jointly influencing COVID-19 and coronary heart diseases
por: Wang, Siyue, et al.
Publicado: (2023)

Development and Validation of a Prediction Model for Cardiovascular Events in Exercise Assessment of Coronary Heart Disease Patients After Percutaneous Coronary Intervention
por: Shen, Tao, et al.
Publicado: (2022)

Integrative analyses of immune-related biomarkers and associated mechanisms in coronary heart disease
por: Zhang, Lianbo, et al.
Publicado: (2022)

Genetic markers of the risk of coronary heart disease and coronary artery thrombosis developing in the Kazakh population
por: Taizhanova, Dana, et al.
Publicado: (2023)

Identification of an Epigenetic Signature for Coronary Heart Disease in Postmenopausal Women's PBMC DNA
por: Zhong, Xiao, et al.
Publicado: (2022)

Identification of Immune Markers in Dilated Cardiomyopathies with Heart Failure by Integrated Weighted Gene Coexpression Network Analysis
por: Wang, Xuehua, et al.
Publicado: (2022)

Identification of metabolic biomarkers in patients with type 2 diabetic coronary heart diseases based on metabolomic approach
por: Liu, Xinfeng, et al.
Publicado: (2016)

Research on Zheng Classification Fusing Pulse Parameters in Coronary Heart Disease
por: Guo, Rui, et al.
Publicado: (2013)

Markers of Endogenous Desaturase Activity and Risk of Coronary Heart Disease in the CAREMA Cohort Study
por: Lu, Yingchang, et al.
Publicado: (2012)

Missense Variant rs28362680 in BTNL2 Reduces Risk of Coronary Heart Disease
por: Zhuo, Jian, et al.
Publicado: (2022)

Development and validation of patient information leaflet for coronary heart disease patients
por: Vinay, B. C., et al.
Publicado: (2021)

Expression of inflammatory factors and oxidative stress markers in serum of patients with coronary heart disease and correlation with coronary artery calcium score
por: Chen, Datong, et al.
Publicado: (2020)

Development and Validation of a Risk Prediction Model for Ventricular Arrhythmia in Elderly Patients with Coronary Heart Disease
por: Dong, Ying, et al.
Publicado: (2021)

Adiposity markers and risk of coronary heart disease in patients with type 2 diabetes mellitus
por: Tonding, Simone F, et al.
Publicado: (2014)

Identification, Validation, and Utilization of Immune Cells in Pancreatic Ductal Adenocarcinoma Based on Marker Genes
por: de Koning, Willem, et al.
Publicado: (2021)

Identification of Markers for Diagnosis and Treatment of Diabetic Kidney Disease Based on the Ferroptosis and Immune
por: Ma, JingYuan, et al.
Publicado: (2022)

Association Between Thromboelastography and Coronary Heart Disease
por: Yang, Liuqiao, et al.
Publicado: (2022)

Development and validation of the coronary heart disease scale under the system of quality of life instruments for chronic diseases QLICD-CHD: combinations of classical test theory and Generalizability theory
por: Wan, Chonghua, et al.
Publicado: (2014)

Development of nutrition label use scale for patients of coronary heart disease and examination of its reliability and validity
por: Pan, Lu, et al.
Publicado: (2023)

Identification of DNA methylation-regulated genes as potential biomarkers for coronary heart disease via machine learning in the Framingham Heart Study
por: Zhang, Xiaokang, et al.
Publicado: (2022)

Identification of a Shared Genetic Susceptibility Locus for Coronary Heart Disease and Periodontitis
por: Schaefer, Arne S., et al.
Publicado: (2009)

Validation of a risk prediction tool for coronary heart disease in middle-aged women
por: De Vito, Katerina M., et al.
Publicado: (2015)

Therapeutic mechanisms of ginseng in coronary heart disease
por: Tang, Miao-Miao, et al.
Publicado: (2023)

Characteristics of coronary arterial lesions in patients with coronary heart disease and hypertension
por: Zhang, Jing-Xia, et al.
Publicado: (2016)

Development and validation of a clinical predictive model for 1-year prognosis in coronary heart disease patients combine with acute heart failure
por: Huang, Xiyi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_934aaguii695p74tjbbthftjli